Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis: The IXORA-PEDS Randomized Clinical Trial.

Paller, Amy S; Seyger, Marieke M B; Magariños, Gabriel A; Pinter, Andreas; Cather, Jennifer C; Rodriguez-Capriles, Claudia; Zhu, Danting; Somani, Najwa; Garrelts, Alyssa; Papp, Kim A

Paller, Amy S; Seyger, Marieke M B; Magariños, Gabriel A; Pinter, Andreas; Cather, Jennifer C; Rodriguez-Capriles, Claudia; Zhu, Danting; Somani, Najwa; Garrelts, Alyssa; Papp, Kim A.

Affiliation

Paller AS; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Seyger MMB; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Magariños GA; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands.
Pinter A; Psoriahue, Buenos Aires, Argentina.
Cather JC; Department of Dermatology, Venereology and Allergology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Rodriguez-Capriles C; Mindful Dermatology and Modern Research Associates, Dallas, Texas.
Zhu D; Eli Lilly and Company, Indianapolis, Indiana.
Somani N; Eli Lilly and Company, Indianapolis, Indiana.
Garrelts A; Eli Lilly and Company, Indianapolis, Indiana.
Papp KA; Eli Lilly and Company, Indianapolis, Indiana.

JAMA Dermatol ; 158(5): 533-541, 2022 05 01.

Article in En | MEDLINE | ID: mdl-35416908

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Antibodies, Monoclonal, Humanized Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Adolescent / Child / Female / Humans Language: En Journal: JAMA Dermatol Year: 2022 Document type: Article Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google